Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell

Status unconfirmed

Conditions studied: Cancer of the Mouth, Oropharynx Squamous Cell Carcinoma

In brief

The goal of this laboratory research study is to learn about symptoms and activity levels of patients with OPSCC that receive IMPT or TORS.

Key facts

Study ID

NCT02663583

Run by

M.D. Anderson Cancer Center

People needed

44

Starts

2016-01-01

Expected to finish

2021-12-01

Last updated by the study team

2019-05-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Histologically documented or suspected, previously untreated OPSCC (Clinical Stage I-Va; Tx,0-2, N0-2b) eligible for standard of care single-modality treatment with either IMPT or TORS. Patients with suspected OPSCC must have a diagnosis confirmed prior to treatment per the current clinical standard of care
• Eastern Cooperative Oncology Group (ECOG) = 0, 1, or 2

You may not qualify if…

• N/A

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.